Statistics
Publications
8
Citations
2.6K
H-Index
8
Active since
1998
Affiliations
A. Fleishman is an author at Amgen (United States) specializing in medicine, chemotherapy, and hematology.
Publications per year
1998–2017
8
8
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Hagop Kantarjian, Anthony S. Stein, Nicola Gökbuget et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text
Medicine, Hematology, Oncology +16
BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
Yiping Tu, Steven Renner, Fei Xu et al. · Dialnet (Universidad de la Rioja) · 1998 · 225 citations
Medicine, Hematology, Oncology +14
John A. Glaspy, J Jadeja, Glen R. Justice et al. · Cancer · 2003 · 89 citations · Full text
1–5 of 8